News & Articles
Aptamer Group grants Alphazyme the right to incorporate Optimer into hot-start PCR and NGS product formulations
Non-exclusive OEM license grants worldwide rights for Optimer binder in molecular biology applications
Thermo Fisher Scientific opens East Coast Collaboration Center
New state-of-the-art facility in Philadelphia provides integrated lab and collaboration space along with tailored guidance to help move advanced therapies from early research to clinical readiness
Successful dosing in new brain cancer treatment from Curasight
Phase 1 trial in aggressive brain cancer (glioblastoma) is the first clinical trial of uTREAT belonging to Curasight's treatment platform
Why labs hold the key to ending hepatitis B and C
Find out why millions of cases of hepatitis B and C are going undiagnosed and how clinical labs could play an important role in getting more people tested and treated
Neuraxpharm standardizes real‑time data exchange across its global supply chain network
The European specialty pharmaceutical company establishes a unified digital data foundation to enable future agentic orchestration
Top mass spectrometry launches of 2025
A comprehensive look at the mass spectrometry technologies powering faster workflows, smarter data, and more accessible analysis across industries
ADAMA and BASF agricultural solutions partner to co-develop breakthrough Gilboa fungicide technology
Gilboa-based formulations for wheat in Great Britain expected in 2027, followed by broader European launches in 2029
Anton Paar introduces its new Xsample series
Scalable automation for low-viscosity samples
CHITOSE and FUJIFILM Biosciences partner to drive global innovation and biopharmaceutical manufacturing
Collaboration formed to accelerate biopharmaceutical manufacturing combining high performing CHO-MK cells and GMP-manufactured culture media
Meeting tomorrow's diagnostic demands in today's lab
President of Diagnostic Solutions at Hologic explains how adopting advanced molecular‑diagnostic technologies is for labs of the future
Amorphical announces positive final long-term results from Phase 2 Crohn's disease trial
Novel treatment offers non-immunosuppressive approach for localized acid neutralization and calcium delivery
Rethinking lab informatics for the next generation of therapeutics
Biopharma needs informatics platforms that are unified, flexible, and intelligent – ready not just for today’s science, but for what is coming next
Thermo Fisher Scientific launches next-generation E. coli Media
New formulations simplify microbial bioprocessing, helping innovators scale plasmid DNA and protein production with confidence
Nominate your favorite new lab product of 2025 for a Scientists’ Choice Award
Tell us which new products have had the biggest impact on your lab work for a chance to win one of four $100 Amazon.com Gift Cards
Chonnam National University uncovers a new molecular target of obesity
Researchers identify RFP protein as a key driver of fat cell formation, opening paths to future obesity treatments
Turning ‘undruggable’ proteins into therapeutic targets
Explore the future of membrane protein therapeutics with innovative antibody platforms
50 years of culturing innovation
Don Whitley Scientific reaches milestone showing unwavering commitment to microbiology
Asynt launches pioneering precision overhead vial stirring for the modern lab
Innovative overhead stirring solution has been designed specifically for compatibility with Asynt DrySyn reaction vial inserts
Exploratory biomarker discovery driven by ultra-sensitive assays
Yao Chen of Sanofi shares how her team achieves sensitivity, specificity, precision, and robustness in protein biomarker detection
Transforming heart disease detection with a new era of laboratory biomarkers
Leading experts reveal how laboratory biomarkers are transforming emergency and long-term cardiac care around the world
Lab Thread announces beta release of Unified Lab Software Platform
Designed to streamline collaboration across biological research, combining real-time data management, analysis, DNA sequence design, chat and review functions within one intuitive, easy to use system
Wolters Kluwer Health and the ABMS team up for quality and safety improvement initiatives
The American Board of Medical Specialties (ABMS) Portfolio Program will leverage Ovid Synthesis, which now features Wolters Kluwer’s Expert AI, to streamline the continuing certification credit process and fast-track patient improvement initiatives
























